The American Recovery and Reinvestment Act (ARRA) of 2009 has dedicated $1.1B to bolster new comparative effectiveness research (CER), patient registries, infrastructure, and dissemination for a period of two years: $300M for Agency of Healthcare Research and Quality (AHRQ), $400M for National Institutes of Health (NIH), and $400M for the Department of Health and Human Services (DHHS). ARRA provided this money in an effort to understand how to better prevent, diagnose, and/or treat diseases throughout the country.
